首页|期刊导航|山西医科大学学报|基于网络药理学与分子动力学模拟探究Moldavoside改善心肌纤维化的机制

基于网络药理学与分子动力学模拟探究Moldavoside改善心肌纤维化的机制OA

Mechanism of Moldavoside alleviating myocardial fibrosis based on network pharmacology and molecular dynamics simulation

中文摘要英文摘要

目的 探讨新疆维吾尔族草药巴迪然吉布亚的有效成分Moldavoside改善心肌纤维化的作用靶点与分子机制.方法 通过网络药理学筛选Moldavoside与心肌纤维化的交集靶点,构建蛋白互作网络并进行GO和KEGG富集分析;采用分子对接与分子动力学模拟验证Moldavoside与关键靶点的结合能力.C57BL/6J小鼠随机分为对照组、Ang Ⅱ组、Ang Ⅱ+Moldavoside组(15 mg/kg每日灌胃,持续28 d);采用天狼星红染色评估心肌纤维化程度,Western blot检测心肌组织JAK1 Tyr1034/Tyr1035位点的磷酸化水平,染色质免疫共沉淀(ChIP)实验验证STAT3对RhoE的转录调控作用.结果 筛选获得60个Moldavoside治疗心肌纤维化的交集靶点,富集分析提示JAK1/STAT3为Moldavoside治疗心肌纤维化的核心通路;分子动力学模拟证实Moldavoside可稳定结合JAK1蛋白.天狼星红染色显示,Ang Ⅱ组心肌纤维化面积较对照组显著升高(5.013±0.517 vs 1.021±0.156,P<0.05),Ang Ⅱ+Moldavoside组较Ang Ⅱ组显著降低(1.060±0.189 vs 5.013±0.515,P<0.05);Western blot结果显示,Ang Ⅱ+Moldavoside组心肌组织中磷酸化JAK1(Tyr1034/Tyr1035)蛋白相对表达水平较Ang Ⅱ组显著降低(0.412±0.076 vs 1.000±0.099,P<0.05).ChIP实验显示STAT3是RhoE的转录因子.结论 Moldavoside可能通过抑制JAK1/STAT3-RhoE通路的激活改善心肌纤维化,可作为治疗心肌纤维化新的候选药物.

Objective To explore the therapeutic targets and molecular mechanisms of Moldavoside,an active ingredient of the traditional Uyghur herbal medicine Badi Ranjibuya,in ameliorating myocardial fibrosis.Methods Network pharmacology was employed to screen intersecting targets between Moldavoside and myocardial fibrosis.A protein-protein interaction network was constructed,and the proteins were analyzed by Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses.Molecular docking and molecular dynamics simulations were performed to evaluate the binding affinity between Moldavoside and the identified key targets.The mice were randomized into control group,angiotensin Ⅱ(Ang Ⅱ)group,and Ang Ⅱ+Moldavoside(daily intragastric administration of Moldavoside at 15 mg/kg for 28 consecutive days)group.Myocardial fibrosis area was assessed by Sirius red staining.The phosphorylation level of JAK1 at Tyr1034/Tyr1035 in myocardial tissues was determined by Western blot.Chromatin immunopre-cipitation(ChIP)assay was performed to verify the transcriptional regulation of RhoE by STAT3.Results A total of 60 intersecting targets of Moldavoside against myocardial fibrosis were identified.Enrichment analyses result indicated that the JAK1/STAT3 pathway was the core signaling pathway mediating the anti-fibrotic effect of Moldavoside.Molecular dynamics simulation results confirmed that Moldavoside could stably bind to the JAK1 protein.Sirius red staining result revealed that the fibrotic area fraction in Ang Ⅱ group was significantly higher than that in control group(5.013±0.517 vs 1.021±0.156,P<0.05),whereas it was significantly lower in Ang Ⅱ+Moldavoside group than in Ang Ⅱ group(1.060±0.189 vs 5.013±0.515,P<0.05).Western blot results demonstrated that the relative protein expression level of phosphorylated JAK1(Tyr1034/Tyr1035)in myocardial tissues was significantly lower in Ang Ⅱ+Moldavo-side group than in Ang Ⅱ group(0.412±0.076 vs 1.000±0.099,P<0.05).The ChIP assay result confirmed that STAT3 was a direct transcription regulator of RhoE.Conclusion Moldavoside can attenuate myocardial fibrosis by suppressing the activation of JAK1/STAT3-RhoE pathway,suggesting that it can be a novel candidate agent for the targeted therapy of myocardial fibrosis.

张碧雪;孙源良;王婷婷;程征;周心涛

新疆医科大学第六附属医院耳鼻喉科,乌鲁木齐 830054西安交通大学第二附属医院呼吸与危重症医学科空军军医大学唐都医院心血管内科新疆医科大学第六附属医院心血管内科||西安交通大学第二附属医院心血管内科||哈尔滨医科大学第二附属医院心血管内科湖北医药学院附属国药东风总医院心血管内科,湖北省高血压临床医学研究中心

医药卫生

MoldavosideRhoE心脏重塑网络药理学分子动力学模拟JAK1/STAT3

MoldavosideRhoEcardiac remodelingnetwork pharmacologymolecular dynamics simulationJAK1/STAT3

《山西医科大学学报》 2026 (8)

875-884,10

国家自然科学基金面上项目(82070282)国家自然科学基金青年项目(82200404)中国博士后基金面上项目(2022MD723777)黑龙江省博士后基金面上项目(LBH-Z22216)陕西省重点研发项目(2023-YBSF-346)新疆维吾尔自治区"天池英才"人才项目:青年博士人才

10.13753/j.issn.1007-6611.2026.08.004

评论